Interview: Grünenthal Reveals Plans To Maintain Robust Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
CSO Klaus Langner discusses the company’s plans to expand beyond its core strength in pain management to niche therapeutic fields.